Aspen Aerogels Inc. (ASPN) is a leading manufacturer and distributor of high-performance aerogel insulation used in a spectrum of industries. The company, based in Northborough, Massachusetts, was founded in 2001. Its proprietary aerogel technology is used to create a variety of products that are highly effective in delivering thermal energy management and condensation control to customers across multiple sectors.
Aspen Aerogels specializes in producing insulation materials that offer superior thermal performance at a fraction of the thickness of traditional insulation products. These materials are used in various applications such as refineries, petrochemical plants, LNG transportation, and even in construction projects with stringent space limitations. Similarly, the company's cutting-edge aerogel insulation is also applied in outdoor gear and clothing, aerospace and defense equipment, and other areas where lightweight, space-saving, and high-performance thermally insulated solutions are required.
The company's business model is built on strong intellectual property rights, with over 30 patents granted in the United States and around the world. Aspen Aerogels revenues come from a diversified customer base which spans several sectors including construction, industrial energy, oil and gas, and beyond.
What sets Aspen Aerogel apart is its continuous commitment to research and development (R&D). The company constantly seeks to innovate, with R&D spending often accounting for more than 10% of its total revenue. It has invested in various research initiatives focused on the development of new aerogel formulations, manufacturing processes, and application technologies.
Aspen Aerogels is publicly traded on the New York Stock Exchange under the ticker symbol "ASPN". Its financial performance, strategic approach, and innovative R&D initiatives have seen it emerge as a key player in the aerogel industry, proving to be a valuable proposition for both its customers and its investors.
In conclusion, Aspen Aerogels Inc is an organization centered on innovation, customer satisfaction, and excellent performance. Its commitment to advanced and efficient insulation technologies delivered via a unique aerogel platform has made it a highly sought-after provider in the field of thermal energy management and condensation control. This company efficiently uses its technology and product offerings to serve various sectors and continues to grow, expand and heighten its global reach and impact.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
This article analyzes Aspen Aerogels Inc. (ASPN), highlighting a strong overweight bias across all time horizons based on AI models. It details three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis emphasizes an exceptional risk-reward setup, targeting a significant gain with minimal risk.
Aspen Aerogels reported strong Q2 2026 financial results with a 32% revenue increase quarter-over-quarter, driven by its PyroThin thermal barrier business. The company provided an optimistic Q3 revenue outlook of $65-$80 million, supported by robust Energy Industrial project deliveries and increased demand for thermal barriers, particularly from European OEMs including a new design award from Jaguar Land Rover. Despite an incident at its East Providence plant, Aspen Aerogels maintains a strong liquidity position and expects full production capacity to be restored by H1 2027, while also exploring Battery Energy Storage Systems as a new growth opportunity.
Craig-Hallum analyst Eric Stine reiterated a Buy rating on Aspen Aerogels (ASPN) with a price target consensus of $7.25. The company's shares closed at $5.22, and Stine has a 14.3% average return on recommended stocks. Despite a recent decline in revenue and increased GAAP net loss, corporate insider sentiment on the stock is negative due to increased selling activity.
Wall Street Zen has downgraded Aspen Aerogels (NYSE:ASPN) from "Hold" to "Sell," despite some analysts maintaining "Buy" ratings and the company exceeding revenue estimates in its latest earnings report. The stock's average rating is now "Hold" with a price target of $5.94, and it continues to face negative profitability metrics. Institutional investors hold a significant majority of the shares.
Barclays has maintained an "Underweight" rating for Aspen Aerogels (ASPN) but raised its price target from $4.00 to $5.00, an increase of 25%. Despite the raised target, analysts express caution due to the stock's 29.1% overvaluation compared to its GF Value™ of $4.81 and its low profitability score of 2/10. The company, which specializes in high-performance aerogel insulation, shows moderate overall performance with a GF Score™ of 67/100 and no insider trading activity in the last three months, suggesting a mixed outlook for investors.